SOUTHFIELD—SyBridge Technologies Inc., a venture-backed acquirer of companies in the tooling and mold industries, announced that it had completed its acquisition of Fairview, Pa.-based X-Cell Tool and Mold Inc.
The purchase marks SyBridge’s first acquisition in the medical tooling industry.
The New York City-based private equity firm Crestview Partners established SyBridge Technologies in Southfield in 2019 and committed $200 million of equity to create a market leader spanning across end markets, geographies, and advanced technological capabilities to provide value-added manufacturing services.
X-Cell makes close-tolerance and multi-cavity plastic injection molds, primarily for the medical industry, while also serving the consumer goods and electronics industries. The company was founded in 1996.
For more information, visit www.sybridgetech.com.
Crestview manages funds with over $9 billion of aggregate capital commitments. Crestview has senior investment professionals focused on sourcing and managing investments in each of the specialty areas of the firm: industrials, media, and financial services. For more information, visit www.crestview.com.